Cargando…
IL-17B/RB Activation in Pancreatic Stellate Cells Promotes Pancreatic Cancer Metabolism and Growth
SIMPLE SUMMARY: Pancreatic cancer has the lowest survival rate of all malignancies. Understanding the interplay between tumor and stroma could lead to the development of new therapies. The metabolic role of interleukin 17B/interleukin 17B receptor (IL-17B/RB) has not been adequately studied in pancr...
Autores principales: | Li, Jiahui, Wu, Xiaolin, Schiffmann, Lars, MacVicar, Thomas, Zhou, Chenghui, Wang, Zhefang, Li, Dai, Camacho, Oscar Velazquez, Heuchel, Reiner, Odenthal, Margarete, Hillmer, Axel, Quaas, Alexander, Zhao, Yue, Bruns, Christiane J., Popp, Felix C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611647/ https://www.ncbi.nlm.nih.gov/pubmed/34771503 http://dx.doi.org/10.3390/cancers13215338 |
Ejemplares similares
-
Aldo-Keto Reductase 1C3 Mediates Chemotherapy Resistance in Esophageal Adenocarcinoma via ROS Detoxification
por: Zhou, Chenghui, et al.
Publicado: (2021) -
Inflammatory IFIT3 renders chemotherapy resistance by regulating post-translational modification of VDAC2 in pancreatic cancer
por: Wang, Zhefang, et al.
Publicado: (2020) -
Targeting Glutaminolysis: New Perspectives to Understand Cancer Development and Novel Strategies for Potential Target Therapies
por: Wang, Zhefang, et al.
Publicado: (2020) -
Tumor-Derived Extracellular Vesicles Inhibit Natural Killer Cell Function in Pancreatic Cancer
por: Zhao, Jiangang, et al.
Publicado: (2019) -
Proposal for a definition of "Oligometastatic disease in pancreatic cancer"
por: Damanakis, Alexander I., et al.
Publicado: (2019)